Article
Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children.
Antimicrobial agents and chemotherapy - 1 Sept 2005
Dzinjalamala Fraction K, Macheso Allan, Kublin James G, Taylor Terrie E, Barnes Karen I, Molyneux Malcolm E, Plowe Christopher V, Smith Peter J
Abstract excerpt
Sulfadoxine-pyrimethamine (SP) has been widely used in recent years to treat acute uncomplicated Plasmodium falciparum malaria. Risk factors for SP therapeutic failure include young age, subtherapeutic SP concentrations, and resistance-conferring genetic mutations in parasite target enzymes. A substantial proportion of patients are able to clear genetically highly resistant P. falciparum genotypes. To determine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
